Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1h2
|
ENSMUSG00000060601.6 | nuclear receptor subfamily 1, group H, member 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_44552632_44552783 | Nr1h2 | 120 | 0.886631 | -0.54 | 2.1e-05 | Click! |
chr7_44552786_44552947 | Nr1h2 | 279 | 0.745068 | -0.43 | 9.9e-04 | Click! |
chr7_44560336_44560487 | Nr1h2 | 6460 | 0.067663 | 0.32 | 1.7e-02 | Click! |
chr7_44553417_44554082 | Nr1h2 | 41 | 0.923279 | 0.31 | 2.3e-02 | Click! |
chr7_44552959_44553404 | Nr1h2 | 31 | 0.925010 | -0.27 | 4.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_146596795_146596946 | 21.02 |
Uox |
urate oxidase |
207 |
0.55 |
chr9_61370339_61371660 | 15.72 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr7_4739300_4740219 | 14.51 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr4_108083536_108083687 | 14.16 |
Mir6397 |
microRNA 6397 |
3746 |
0.17 |
chr17_31073159_31073638 | 14.08 |
Gm25447 |
predicted gene, 25447 |
13794 |
0.13 |
chr1_191641396_191641769 | 14.00 |
Gm37349 |
predicted gene, 37349 |
43935 |
0.11 |
chr3_95661987_95662266 | 13.72 |
Mcl1 |
myeloid cell leukemia sequence 1 |
3269 |
0.13 |
chr2_129226173_129226353 | 13.19 |
9830144P21Rik |
RIKEN cDNA 9830144P21 gene |
175 |
0.88 |
chr19_44283591_44284731 | 13.06 |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
9513 |
0.11 |
chr2_163541937_163542094 | 12.45 |
Hnf4aos |
hepatic nuclear factor 4 alpha, opposite strand |
295 |
0.85 |
chr1_170325418_170325569 | 12.18 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
1138 |
0.43 |
chr1_133685767_133686128 | 12.02 |
Lax1 |
lymphocyte transmembrane adaptor 1 |
4139 |
0.15 |
chr9_47321173_47321428 | 11.64 |
Gm31816 |
predicted gene, 31816 |
41450 |
0.18 |
chr14_75837044_75838069 | 11.41 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr17_71235414_71235565 | 11.24 |
Lpin2 |
lipin 2 |
3173 |
0.22 |
chr2_158305932_158306715 | 11.22 |
Lbp |
lipopolysaccharide binding protein |
170 |
0.92 |
chr12_7919774_7920221 | 11.22 |
Gm18387 |
predicted gene, 18387 |
22424 |
0.15 |
chr14_76817069_76817629 | 11.16 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr10_54038165_54038485 | 10.76 |
Gm47917 |
predicted gene, 47917 |
25486 |
0.18 |
chr9_107975396_107975585 | 10.39 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
15 |
0.92 |
chr8_11458639_11458838 | 10.26 |
Gm20100 |
predicted gene, 20100 |
1004 |
0.41 |
chr5_91292941_91293393 | 10.24 |
Gm19619 |
predicted gene, 19619 |
9746 |
0.24 |
chr10_41262026_41262186 | 10.21 |
Fig4 |
FIG4 phosphoinositide 5-phosphatase |
41154 |
0.11 |
chr2_104098671_104098841 | 10.11 |
Cd59a |
CD59a antigen |
2916 |
0.17 |
chr5_125249279_125249435 | 9.68 |
Gm32585 |
predicted gene, 32585 |
23458 |
0.16 |
chr14_14351950_14353283 | 9.65 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr15_103257848_103258200 | 9.63 |
Nfe2 |
nuclear factor, erythroid derived 2 |
379 |
0.75 |
chr16_4702700_4702994 | 9.59 |
Nmral1 |
NmrA-like family domain containing 1 |
16241 |
0.1 |
chr13_45391635_45391829 | 9.48 |
Mylip |
myosin regulatory light chain interacting protein |
805 |
0.69 |
chr9_70914684_70915036 | 9.46 |
Gm32017 |
predicted gene, 32017 |
15628 |
0.19 |
chr17_42884465_42884760 | 9.45 |
Cd2ap |
CD2-associated protein |
7947 |
0.29 |
chr4_46404152_46404582 | 9.44 |
Hemgn |
hemogen |
131 |
0.94 |
chr5_146687980_146688258 | 9.41 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
18503 |
0.16 |
chr16_95439185_95439529 | 9.41 |
Erg |
ETS transcription factor |
19888 |
0.24 |
chr18_20920762_20920923 | 9.35 |
Rnf125 |
ring finger protein 125 |
23783 |
0.17 |
chr4_117829604_117830012 | 9.32 |
Gm12842 |
predicted gene 12842 |
4152 |
0.14 |
chr11_99314638_99314789 | 9.26 |
Krt25 |
keratin 25 |
8238 |
0.1 |
chr4_107302679_107302834 | 9.14 |
Dio1 |
deiodinase, iodothyronine, type I |
4310 |
0.14 |
chr5_36736135_36736430 | 9.13 |
Gm43701 |
predicted gene 43701 |
12336 |
0.12 |
chr2_104098945_104099129 | 9.05 |
Cd59a |
CD59a antigen |
3197 |
0.16 |
chr10_117663165_117663366 | 9.05 |
Gm25709 |
predicted gene, 25709 |
877 |
0.51 |
chr2_167856124_167856275 | 8.98 |
Gm14319 |
predicted gene 14319 |
2386 |
0.26 |
chr16_93725844_93726021 | 8.92 |
Dop1b |
DOP1 leucine zipper like protein B |
4167 |
0.19 |
chr12_79272716_79273016 | 8.90 |
Zfyve26 |
zinc finger, FYVE domain containing 26 |
4453 |
0.2 |
chr5_140597227_140597396 | 8.75 |
Gm43703 |
predicted gene 43703 |
9240 |
0.13 |
chrX_77473456_77473641 | 8.69 |
Gm5937 |
predicted gene 5937 |
16962 |
0.22 |
chr11_53903923_53904112 | 8.65 |
Gm12218 |
predicted gene 12218 |
862 |
0.4 |
chr4_136187267_136187442 | 8.52 |
E2f2 |
E2F transcription factor 2 |
6571 |
0.15 |
chr3_10041049_10041236 | 8.48 |
Gm38335 |
predicted gene, 38335 |
15603 |
0.15 |
chr1_156745176_156745463 | 8.46 |
Fam20b |
family with sequence similarity 20, member B |
26233 |
0.14 |
chr18_39466946_39467170 | 8.41 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
20174 |
0.22 |
chr4_129464231_129464446 | 8.34 |
Bsdc1 |
BSD domain containing 1 |
204 |
0.88 |
chr13_101861969_101862287 | 8.32 |
Gm47007 |
predicted gene, 47007 |
6637 |
0.22 |
chr7_109600775_109601173 | 8.31 |
Denn2b |
DENN domain containing 2B |
1691 |
0.34 |
chr11_28685558_28685711 | 8.25 |
2810471M01Rik |
RIKEN cDNA 2810471M01 gene |
4070 |
0.23 |
chr8_125711418_125711569 | 8.17 |
Ntpcr |
nucleoside-triphosphatase, cancer-related |
18470 |
0.2 |
chr17_31305571_31305760 | 8.13 |
Slc37a1 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 1 |
122 |
0.95 |
chr11_98394957_98395469 | 8.10 |
Pgap3 |
post-GPI attachment to proteins 3 |
3141 |
0.11 |
chr1_180981412_180981591 | 8.07 |
Gm36961 |
predicted gene, 36961 |
5212 |
0.1 |
chr4_134814281_134814466 | 7.94 |
Maco1 |
macoilin 1 |
3160 |
0.25 |
chr12_110220612_110220914 | 7.94 |
Gm40576 |
predicted gene, 40576 |
15599 |
0.11 |
chr14_8244059_8244558 | 7.90 |
Acox2 |
acyl-Coenzyme A oxidase 2, branched chain |
2095 |
0.32 |
chr3_52502231_52502591 | 7.88 |
Gm30173 |
predicted gene, 30173 |
14553 |
0.23 |
chr7_110941126_110941340 | 7.87 |
Mrvi1 |
MRV integration site 1 |
4954 |
0.21 |
chr17_47909349_47909983 | 7.83 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr2_79259164_79259332 | 7.76 |
Itga4 |
integrin alpha 4 |
3301 |
0.3 |
chr2_26593817_26594312 | 7.75 |
Egfl7 |
EGF-like domain 7 |
1917 |
0.15 |
chr6_124683793_124684111 | 7.75 |
Lpcat3 |
lysophosphatidylcholine acyltransferase 3 |
17467 |
0.06 |
chr3_67311537_67311688 | 7.72 |
Mlf1 |
myeloid leukemia factor 1 |
62485 |
0.11 |
chrX_93928381_93928666 | 7.70 |
Gm15164 |
predicted gene 15164 |
3038 |
0.21 |
chr12_101028530_101029714 | 7.69 |
Ccdc88c |
coiled-coil domain containing 88C |
66 |
0.95 |
chr16_91865276_91865445 | 7.68 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
3334 |
0.21 |
chr18_20920929_20921100 | 7.64 |
Rnf125 |
ring finger protein 125 |
23611 |
0.17 |
chr6_28459197_28459489 | 7.63 |
Gm43264 |
predicted gene 43264 |
7638 |
0.12 |
chr13_96742964_96743239 | 7.58 |
Ankrd31 |
ankyrin repeat domain 31 |
5171 |
0.2 |
chr16_11198579_11198769 | 7.57 |
Rsl1d1 |
ribosomal L1 domain containing 1 |
3679 |
0.11 |
chr5_100638641_100638903 | 7.54 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
25647 |
0.12 |
chr1_180902923_180903097 | 7.50 |
Pycr2 |
pyrroline-5-carboxylate reductase family, member 2 |
1283 |
0.27 |
chr6_93014650_93014830 | 7.48 |
Gm44224 |
predicted gene, 44224 |
64368 |
0.11 |
chr18_82523055_82523247 | 7.48 |
Rpl21-ps8 |
ribosomal protein L21, pseudogene 8 |
870 |
0.6 |
chr17_29440014_29440223 | 7.47 |
Gm36486 |
predicted gene, 36486 |
2670 |
0.17 |
chr17_83846798_83846973 | 7.46 |
Haao |
3-hydroxyanthranilate 3,4-dioxygenase |
73 |
0.97 |
chr6_149310741_149310934 | 7.38 |
Resf1 |
retroelement silencing factor 1 |
579 |
0.7 |
chr2_28597592_28597756 | 7.37 |
Gm22675 |
predicted gene, 22675 |
2547 |
0.16 |
chr6_34869825_34870042 | 7.35 |
Tmem140 |
transmembrane protein 140 |
2781 |
0.17 |
chr3_104360493_104360669 | 7.31 |
Gm5546 |
predicted gene 5546 |
6032 |
0.18 |
chr11_97424148_97424313 | 7.30 |
Arhgap23 |
Rho GTPase activating protein 23 |
8697 |
0.16 |
chr16_94544597_94544789 | 7.27 |
Vps26c |
VPS26 endosomal protein sorting factor C |
17863 |
0.16 |
chr19_44248110_44249062 | 7.26 |
Gm50323 |
predicted gene, 50323 |
2016 |
0.19 |
chr6_86660605_86660917 | 7.25 |
Mxd1 |
MAX dimerization protein 1 |
2344 |
0.17 |
chr6_87583790_87584040 | 7.21 |
Prokr1 |
prokineticin receptor 1 |
6804 |
0.14 |
chr7_100500401_100501097 | 7.20 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
2403 |
0.14 |
chr3_129838135_129838300 | 7.16 |
Cfi |
complement component factor i |
1480 |
0.29 |
chr14_51130146_51130325 | 7.16 |
Rnase6 |
ribonuclease, RNase A family, 6 |
1154 |
0.27 |
chr10_128664909_128665171 | 7.16 |
Ikzf4 |
IKAROS family zinc finger 4 |
4318 |
0.09 |
chr7_135816621_135817118 | 7.15 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
36813 |
0.12 |
chr11_53805889_53806048 | 7.09 |
Gm12216 |
predicted gene 12216 |
10093 |
0.12 |
chr3_89293654_89293827 | 7.09 |
Efna1 |
ephrin A1 |
12598 |
0.06 |
chr3_37903598_37903749 | 7.08 |
Gm20755 |
predicted gene, 20755 |
4860 |
0.19 |
chr9_110699835_110699986 | 7.07 |
Ccdc12 |
coiled-coil domain containing 12 |
9984 |
0.11 |
chr15_9114613_9115328 | 7.07 |
Nadk2 |
NAD kinase 2, mitochondrial |
11982 |
0.18 |
chr12_116269265_116269416 | 7.04 |
Gm11027 |
predicted gene 11027 |
6046 |
0.13 |
chr7_28432486_28432642 | 7.03 |
Samd4b |
sterile alpha motif domain containing 4B |
3627 |
0.1 |
chr10_95839927_95840078 | 7.03 |
Gm33543 |
predicted gene, 33543 |
2894 |
0.18 |
chr1_59175112_59175285 | 7.00 |
Mpp4 |
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
11809 |
0.13 |
chr10_80160842_80161483 | 6.99 |
Cirbp |
cold inducible RNA binding protein |
4823 |
0.09 |
chr8_106136769_106137557 | 6.93 |
1810019D21Rik |
RIKEN cDNA 1810019D21 gene |
98 |
0.62 |
chr5_96951235_96951434 | 6.88 |
Gm43144 |
predicted gene 43144 |
11037 |
0.1 |
chr4_41096817_41097151 | 6.85 |
Aqp3 |
aquaporin 3 |
1199 |
0.33 |
chr7_84167435_84167623 | 6.80 |
Gm22177 |
predicted gene, 22177 |
3036 |
0.2 |
chr5_137530580_137532081 | 6.80 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr5_65350921_65351072 | 6.80 |
Klb |
klotho beta |
2588 |
0.17 |
chr11_84828418_84829673 | 6.78 |
Dhrs11 |
dehydrogenase/reductase (SDR family) member 11 |
51 |
0.6 |
chr17_29420071_29420232 | 6.77 |
Gm36199 |
predicted gene, 36199 |
12684 |
0.12 |
chr7_4629736_4629951 | 6.76 |
Tmem86b |
transmembrane protein 86B |
344 |
0.69 |
chr5_100566956_100567158 | 6.76 |
Plac8 |
placenta-specific 8 |
3634 |
0.17 |
chr5_129730352_129730723 | 6.73 |
Gm15903 |
predicted gene 15903 |
2365 |
0.17 |
chr1_191037110_191037261 | 6.70 |
Spata45 |
spermatogenesis associated 45 |
366 |
0.74 |
chr3_97615238_97615451 | 6.68 |
Chd1l |
chromodomain helicase DNA binding protein 1-like |
5141 |
0.16 |
chr2_152813891_152814057 | 6.67 |
Bcl2l1 |
BCL2-like 1 |
14561 |
0.12 |
chr6_120175832_120176043 | 6.66 |
Ninj2 |
ninjurin 2 |
17886 |
0.19 |
chr4_106195623_106195848 | 6.64 |
Gm12724 |
predicted gene 12724 |
45481 |
0.11 |
chr1_189757364_189757562 | 6.64 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
29173 |
0.16 |
chr11_63883505_63883669 | 6.63 |
Hmgb1-ps3 |
high mobility group box 1, pseudogene 3 |
36769 |
0.15 |
chr11_118470223_118470520 | 6.62 |
Engase |
endo-beta-N-acetylglucosaminidase |
6458 |
0.13 |
chr4_140700990_140701441 | 6.61 |
Rcc2 |
regulator of chromosome condensation 2 |
258 |
0.87 |
chr7_141508026_141508712 | 6.57 |
Gm45416 |
predicted gene 45416 |
10234 |
0.08 |
chr6_87746996_87747194 | 6.54 |
Efcc1 |
EF hand and coiled-coil domain containing 1 |
6427 |
0.09 |
chr7_28179836_28180482 | 6.45 |
Dyrk1b |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
107 |
0.93 |
chrX_36814558_36814733 | 6.44 |
Gm14549 |
predicted gene 14549 |
126 |
0.94 |
chr2_128084610_128085080 | 6.41 |
Gm23101 |
predicted gene, 23101 |
5079 |
0.25 |
chr11_96141010_96141191 | 6.40 |
Ttll6 |
tubulin tyrosine ligase-like family, member 6 |
6881 |
0.12 |
chr19_5845343_5846183 | 6.37 |
Frmd8os |
FERM domain containing 8, opposite strand |
140 |
0.66 |
chr4_135277044_135277240 | 6.33 |
Clic4 |
chloride intracellular channel 4 (mitochondrial) |
4328 |
0.15 |
chr13_46021024_46021218 | 6.32 |
Gm45949 |
predicted gene, 45949 |
39476 |
0.15 |
chr5_103753230_103754272 | 6.32 |
Aff1 |
AF4/FMR2 family, member 1 |
411 |
0.87 |
chr8_11021286_11021447 | 6.31 |
Irs2 |
insulin receptor substrate 2 |
12908 |
0.13 |
chr1_67077762_67078048 | 6.30 |
Lancl1 |
LanC (bacterial lantibiotic synthetase component C)-like 1 |
39033 |
0.15 |
chr4_154120765_154120954 | 6.29 |
Trp73 |
transformation related protein 73 |
4254 |
0.13 |
chr1_151103116_151103350 | 6.29 |
Gm19087 |
predicted gene, 19087 |
4682 |
0.15 |
chr9_124112644_124112818 | 6.26 |
Ccr2 |
chemokine (C-C motif) receptor 2 |
7105 |
0.2 |
chr8_41132677_41132828 | 6.25 |
Mtus1 |
mitochondrial tumor suppressor 1 |
966 |
0.6 |
chr10_43646429_43646600 | 6.23 |
Rpl26-ps1 |
ribosomal protein L26, pseudogene 1 |
7291 |
0.13 |
chr6_84640633_84641008 | 6.23 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
46912 |
0.17 |
chr18_40219232_40219962 | 6.19 |
Yipf5 |
Yip1 domain family, member 5 |
168 |
0.95 |
chr16_91804884_91805073 | 6.17 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
342 |
0.88 |
chr3_144198270_144199266 | 6.16 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr11_44519752_44520312 | 6.16 |
Rnf145 |
ring finger protein 145 |
273 |
0.91 |
chr15_96673958_96674109 | 6.12 |
Gm22045 |
predicted gene, 22045 |
2240 |
0.28 |
chr1_185731219_185731388 | 6.10 |
Gm38093 |
predicted gene, 38093 |
13500 |
0.27 |
chr17_84650660_84650983 | 6.10 |
Dync2li1 |
dynein cytoplasmic 2 light intermediate chain 1 |
1546 |
0.3 |
chr1_151619279_151619636 | 6.09 |
Fam129a |
family with sequence similarity 129, member A |
47961 |
0.12 |
chr5_73194121_73194321 | 6.04 |
Fryl |
FRY like transcription coactivator |
2342 |
0.2 |
chr19_4497542_4497945 | 6.04 |
2010003K11Rik |
RIKEN cDNA 2010003K11 gene |
840 |
0.5 |
chr4_148676695_148676885 | 6.02 |
Gm572 |
predicted gene 572 |
33473 |
0.11 |
chr2_165968946_165969159 | 6.01 |
Gm11462 |
predicted gene 11462 |
9263 |
0.13 |
chr7_141476698_141477340 | 6.00 |
Tspan4 |
tetraspanin 4 |
619 |
0.43 |
chr7_68708665_68708864 | 5.98 |
Gm44692 |
predicted gene 44692 |
17703 |
0.21 |
chr19_43792398_43792549 | 5.97 |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
5513 |
0.16 |
chr7_19693317_19693822 | 5.95 |
Apoc1 |
apolipoprotein C-I |
909 |
0.31 |
chr4_150799750_150799901 | 5.94 |
Gm13049 |
predicted gene 13049 |
25908 |
0.15 |
chr7_16405093_16405902 | 5.93 |
Gm45508 |
predicted gene 45508 |
1235 |
0.27 |
chr16_76314698_76314885 | 5.93 |
Nrip1 |
nuclear receptor interacting protein 1 |
8867 |
0.25 |
chr16_97497682_97498061 | 5.92 |
Gm24777 |
predicted gene, 24777 |
1151 |
0.37 |
chr4_41755377_41756360 | 5.87 |
Galt |
galactose-1-phosphate uridyl transferase |
28 |
0.78 |
chr11_61074803_61074968 | 5.86 |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
9081 |
0.17 |
chr15_84325216_84325381 | 5.85 |
Parvg |
parvin, gamma |
503 |
0.72 |
chr14_63117678_63117839 | 5.85 |
Ctsb |
cathepsin B |
4704 |
0.15 |
chr13_91749984_91750135 | 5.85 |
Gm27656 |
predicted gene, 27656 |
2047 |
0.25 |
chr15_7167953_7168132 | 5.81 |
Lifr |
LIF receptor alpha |
13689 |
0.25 |
chr11_101641885_101642222 | 5.81 |
Gm24950 |
predicted gene, 24950 |
305 |
0.77 |
chr4_41013453_41013635 | 5.81 |
Nfx1 |
nuclear transcription factor, X-box binding 1 |
4337 |
0.14 |
chr13_5803953_5804153 | 5.80 |
Gm26043 |
predicted gene, 26043 |
17805 |
0.19 |
chr8_46332776_46332927 | 5.79 |
Gm45255 |
predicted gene 45255 |
19050 |
0.11 |
chr15_36321586_36321746 | 5.77 |
Rpl7a-ps3 |
ribosomal protein L7A, pseudogene 3 |
12722 |
0.12 |
chr5_134639209_134639739 | 5.76 |
Eif4h |
eukaryotic translation initiation factor 4H |
16 |
0.96 |
chr16_76242899_76243212 | 5.75 |
Nrip1 |
nuclear receptor interacting protein 1 |
80603 |
0.09 |
chr11_97210790_97210941 | 5.75 |
Npepps |
aminopeptidase puromycin sensitive |
1597 |
0.28 |
chr19_3834443_3834636 | 5.75 |
Gm19209 |
predicted gene, 19209 |
12150 |
0.09 |
chr19_9924707_9924858 | 5.75 |
Gm36913 |
predicted gene, 36913 |
3752 |
0.1 |
chr7_132738377_132738763 | 5.74 |
Fam53b |
family with sequence similarity 53, member B |
38346 |
0.14 |
chr1_135847182_135847352 | 5.72 |
Tnnt2 |
troponin T2, cardiac |
2183 |
0.22 |
chr8_64746454_64746717 | 5.72 |
Klhl2 |
kelch-like 2, Mayven |
8386 |
0.16 |
chr5_74062664_74062828 | 5.72 |
Gm43415 |
predicted gene 43415 |
2708 |
0.15 |
chr15_25650471_25650697 | 5.70 |
Gm48996 |
predicted gene, 48996 |
15957 |
0.17 |
chr17_31039696_31039859 | 5.70 |
Abcg1 |
ATP binding cassette subfamily G member 1 |
17898 |
0.12 |
chr5_53074680_53074843 | 5.68 |
Slc34a2 |
solute carrier family 34 (sodium phosphate), member 2 |
25408 |
0.15 |
chr7_90043630_90043791 | 5.68 |
Gm44861 |
predicted gene 44861 |
1013 |
0.43 |
chr2_152806174_152806420 | 5.67 |
Bcl2l1 |
BCL2-like 1 |
22238 |
0.11 |
chr15_95917019_95917181 | 5.66 |
Ano6 |
anoctamin 6 |
21494 |
0.17 |
chr6_84043380_84043531 | 5.66 |
Gm7498 |
predicted gene 7498 |
11867 |
0.15 |
chr12_105034890_105035385 | 5.64 |
Glrx5 |
glutaredoxin 5 |
79 |
0.94 |
chr11_11933113_11933264 | 5.64 |
Grb10 |
growth factor receptor bound protein 10 |
5428 |
0.2 |
chr1_171123034_171123381 | 5.60 |
Cfap126 |
cilia and flagella associated protein 126 |
33 |
0.95 |
chr19_25138323_25138528 | 5.59 |
Dock8 |
dedicator of cytokinesis 8 |
11033 |
0.22 |
chr11_120528987_120529140 | 5.59 |
Gm11789 |
predicted gene 11789 |
1491 |
0.15 |
chr8_76898822_76900180 | 5.57 |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
59 |
0.89 |
chrX_53088731_53089002 | 5.57 |
Plac1 |
placental specific protein 1 |
25664 |
0.08 |
chr6_67149473_67149848 | 5.56 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
15264 |
0.15 |
chr12_40966432_40966583 | 5.56 |
Gm18246 |
predicted gene, 18246 |
49219 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 13.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.7 | 10.9 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
2.7 | 5.4 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
2.6 | 7.7 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.4 | 7.1 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
2.2 | 8.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.2 | 4.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.2 | 6.5 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
2.0 | 6.1 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.9 | 9.7 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.9 | 9.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.8 | 12.9 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.8 | 1.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.8 | 10.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.7 | 6.8 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
1.7 | 5.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.7 | 6.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.6 | 8.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.5 | 6.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.5 | 4.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.5 | 6.1 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.4 | 1.4 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
1.4 | 7.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.4 | 5.6 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
1.4 | 4.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.3 | 4.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.3 | 4.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.3 | 4.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.3 | 6.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.3 | 6.3 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.2 | 3.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.2 | 7.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.2 | 3.5 | GO:0015793 | glycerol transport(GO:0015793) |
1.2 | 2.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.2 | 3.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 5.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.1 | 6.9 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.1 | 3.4 | GO:0050904 | diapedesis(GO:0050904) |
1.1 | 5.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.1 | 9.0 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
1.1 | 3.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.1 | 3.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.0 | 2.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.0 | 4.1 | GO:0008228 | opsonization(GO:0008228) |
1.0 | 5.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.0 | 3.1 | GO:0035483 | gastric emptying(GO:0035483) |
1.0 | 2.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
1.0 | 6.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.0 | 2.9 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.0 | 2.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.0 | 4.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
1.0 | 4.8 | GO:0015886 | heme transport(GO:0015886) |
0.9 | 3.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.9 | 4.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.9 | 2.8 | GO:0030242 | pexophagy(GO:0030242) |
0.9 | 2.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.9 | 4.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.9 | 2.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.9 | 2.7 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.9 | 2.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.9 | 1.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.9 | 2.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.9 | 2.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 1.8 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.9 | 1.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.9 | 0.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.9 | 2.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.9 | 1.7 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.8 | 4.2 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.8 | 6.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.8 | 2.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.8 | 2.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.8 | 4.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.8 | 2.5 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.8 | 0.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.8 | 4.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.8 | 6.4 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.8 | 3.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.8 | 3.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.8 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.8 | 1.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.8 | 3.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.8 | 2.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.8 | 3.8 | GO:0015879 | carnitine transport(GO:0015879) |
0.7 | 3.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.7 | 4.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.7 | 3.0 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.7 | 2.2 | GO:0015817 | histidine transport(GO:0015817) |
0.7 | 2.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.7 | 3.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 4.3 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.7 | 2.1 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.7 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.7 | 2.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.7 | 1.4 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.7 | 2.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.7 | 4.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.7 | 5.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.7 | 1.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.7 | 2.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.7 | 6.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.7 | 2.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.7 | 4.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.7 | 0.7 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.7 | 2.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.6 | 0.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.6 | 9.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.6 | 1.3 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 5.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.6 | 3.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 1.3 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.6 | 1.9 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.6 | 3.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 3.1 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.6 | 2.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.6 | 1.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.6 | 1.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 | 3.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.6 | 6.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.6 | 7.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.6 | 2.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.6 | 1.8 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.6 | 2.9 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.6 | 1.8 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.6 | 2.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.6 | 1.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 2.3 | GO:0036233 | glycine import(GO:0036233) |
0.6 | 1.1 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.6 | 2.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 1.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.6 | 1.7 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.6 | 2.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.6 | 3.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 1.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.6 | 1.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.6 | 1.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 0.6 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.6 | 1.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 3.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.5 | 0.5 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.5 | 1.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.5 | 2.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 1.6 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.5 | 2.7 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.5 | 1.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.5 | 1.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.5 | 2.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 3.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 1.0 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.5 | 2.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 2.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.5 | 3.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.5 | 1.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 5.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.5 | 2.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.5 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 1.5 | GO:0032782 | bile acid secretion(GO:0032782) |
0.5 | 1.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 3.6 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 3.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 1.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.5 | 1.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 3.5 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.5 | 2.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.5 | 1.0 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 2.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 1.5 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 1.9 | GO:0032264 | IMP salvage(GO:0032264) |
0.5 | 1.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 1.4 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.5 | 3.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.5 | 0.5 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.5 | 3.8 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.5 | 1.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 0.9 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.5 | 1.8 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.5 | 2.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 0.9 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.5 | 0.9 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.5 | 1.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 0.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.5 | 0.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 0.9 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.5 | 0.5 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.5 | 4.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 0.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.4 | 1.3 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 2.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 2.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 3.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 2.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 6.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.4 | 0.9 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.4 | 1.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.4 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 2.6 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.4 | 2.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 3.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.4 | 0.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 4.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 3.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 5.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.4 | 6.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 14.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.4 | 1.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 1.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.4 | 2.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.4 | 7.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 0.4 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.4 | 3.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 0.8 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.4 | 2.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.4 | 1.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 7.8 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.4 | 3.7 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 1.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 0.8 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.4 | 2.0 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 2.8 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.4 | 1.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 4.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 2.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 4.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 0.8 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.4 | 2.7 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.4 | 3.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 2.3 | GO:0097421 | liver regeneration(GO:0097421) |
0.4 | 0.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.4 | 1.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.4 | 3.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 1.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 0.8 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 1.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 1.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 3.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 4.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 0.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.4 | 1.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 0.4 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.4 | 1.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 1.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.4 | 3.3 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.4 | 1.8 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 1.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.4 | 0.4 | GO:0071947 | protein K29-linked deubiquitination(GO:0035523) protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 2.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 1.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.4 | 1.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 0.7 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 6.4 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.4 | 1.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 1.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 3.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 1.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 1.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 1.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 1.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 3.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 1.7 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.3 | 0.7 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.3 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 1.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 1.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 3.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 0.7 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.3 | 1.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 1.0 | GO:1901145 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
0.3 | 2.0 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.3 | 2.6 | GO:0097286 | iron ion import(GO:0097286) |
0.3 | 0.3 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 1.6 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 1.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 2.6 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.3 | 8.5 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 1.0 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 2.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.3 | 2.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 1.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 0.6 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.3 | 1.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 1.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 1.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 1.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 0.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.3 | 0.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.3 | 0.3 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.3 | 1.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 1.6 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 0.3 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 0.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.3 | 0.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.3 | 0.9 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.3 | 0.3 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 0.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 0.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 0.6 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.3 | 2.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.3 | 1.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 1.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.3 | 0.6 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.3 | 6.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 0.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.9 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.3 | 0.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 0.6 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.9 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 1.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.3 | 0.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.3 | 0.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.3 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.3 | 0.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 2.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.3 | 1.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 3.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.3 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 1.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 1.7 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 0.3 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 0.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 0.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 0.3 | GO:0071351 | response to interleukin-12(GO:0070671) response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.3 | 0.8 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 1.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 0.8 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.3 | 0.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 0.8 | GO:0030730 | positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
0.3 | 2.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 1.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 1.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.6 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 2.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 1.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 1.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.3 | 0.6 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 0.5 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 1.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 0.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 0.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 0.3 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.3 | 0.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 3.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 0.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.8 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 0.8 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.3 | 1.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 1.0 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 0.5 | GO:0001705 | ectoderm formation(GO:0001705) |
0.3 | 1.0 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 0.5 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.3 | 2.0 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 2.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 0.3 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.3 | 1.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 1.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 2.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 2.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 0.8 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 4.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 3.8 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.3 | 5.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 0.3 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.2 | 1.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 4.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.5 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 3.0 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.2 | 0.2 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.2 | 2.7 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 1.2 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.5 | GO:0071871 | response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) |
0.2 | 1.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 2.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 1.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 0.7 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 0.5 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 1.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 1.9 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.5 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.2 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 0.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 2.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.2 | 3.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.5 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 0.2 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.2 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 2.1 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.2 | 0.2 | GO:2000848 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of glucocorticoid secretion(GO:2000851) |
0.2 | 0.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 4.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 1.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.2 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.2 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 2.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 0.7 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.2 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.9 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 1.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 2.2 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 0.4 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.2 | 0.7 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.2 | 0.9 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 1.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.4 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 1.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 2.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 2.4 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.2 | 3.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.2 | 0.2 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.2 | 0.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 11.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 1.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.4 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 9.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 3.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 0.4 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.2 | 1.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 1.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 1.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 5.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 0.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 1.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.4 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.4 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.2 | 0.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.4 | GO:0086029 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.2 | 0.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 1.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 5.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 0.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 1.0 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 2.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.2 | 4.5 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.4 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 1.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 0.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.6 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 0.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 3.3 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 1.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 1.5 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.2 | 3.8 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.2 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 1.7 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 2.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 1.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.6 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.4 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.2 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.4 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 0.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 6.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.6 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 0.6 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.2 | 0.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.2 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.2 | 0.2 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.5 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.2 | 1.3 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 2.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 4.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 1.3 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
0.2 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 2.0 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 0.9 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.5 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.7 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 0.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 0.8 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.2 | 0.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 1.9 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 3.4 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 0.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 1.5 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 0.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 0.5 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.7 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.2 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.2 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.2 | 0.2 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.2 | 1.5 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.2 | 0.3 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.8 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.2 | 2.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 0.5 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.2 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.3 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 0.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 2.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.5 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.2 | 0.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 1.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 2.9 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
0.2 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.2 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 1.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.5 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 3.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.6 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.3 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.2 | 0.8 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 1.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.2 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 0.2 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 2.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 2.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 0.5 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.5 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.2 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 1.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.3 | GO:1904684 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.4 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 1.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.7 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 1.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 1.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 1.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 0.1 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.1 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 1.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 1.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.7 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.1 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 4.7 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 2.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 3.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 1.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.3 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 5.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.7 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 1.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 2.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.5 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 4.9 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.9 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 1.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 1.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.4 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 1.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.4 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.4 | GO:1903912 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 2.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 1.4 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 6.7 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 0.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.1 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.1 | 2.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 5.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.1 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.1 | 0.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 3.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 1.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.1 | 2.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 3.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:1903911 | positive regulation of receptor clustering(GO:1903911) |
0.1 | 0.9 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.5 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 1.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 0.1 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 1.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 1.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.5 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 1.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 3.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.2 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.9 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 4.8 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 1.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.9 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.1 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 1.8 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.3 | GO:0046813 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.6 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 1.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.3 | GO:1903332 | regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
0.1 | 0.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 1.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 1.1 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 2.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 3.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.1 | 0.7 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 1.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 5.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.4 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.2 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 0.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.7 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 1.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.8 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 1.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.2 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.1 | 0.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.3 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.6 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 2.9 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 1.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 2.6 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 0.4 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.1 | 0.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.4 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 1.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 1.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.9 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.3 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 2.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 1.0 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 3.7 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 1.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.8 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.7 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.1 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 1.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.2 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.3 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.3 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.3 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 0.3 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 1.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.3 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.3 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
0.1 | 0.8 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.3 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.7 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.6 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.2 | GO:0032511 | endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.4 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.5 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.6 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.1 | 0.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 2.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 1.0 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.1 | GO:0071868 | cellular response to monoamine stimulus(GO:0071868) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.1 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0070375 | ventricular cardiac myofibril assembly(GO:0055005) ERK5 cascade(GO:0070375) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 1.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 1.2 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.1 | 0.1 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.2 | GO:0071051 | U4 snRNA 3'-end processing(GO:0034475) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 1.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.5 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 3.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.3 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.1 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.1 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.4 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.1 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.1 | 0.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.4 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.1 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.1 | 0.1 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.1 | 0.7 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.2 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.1 | GO:0046060 | dATP metabolic process(GO:0046060) dATP catabolic process(GO:0046061) |
0.1 | 0.3 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.1 | 0.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.5 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.3 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.1 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 1.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.2 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 1.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.1 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.4 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.1 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.1 | 2.3 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.5 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 1.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.4 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 2.3 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.1 | 0.1 | GO:0051197 | positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 1.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.1 | 0.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.1 | GO:0006949 | syncytium formation by plasma membrane fusion(GO:0000768) syncytium formation(GO:0006949) |
0.1 | 0.2 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.5 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.1 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.3 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.3 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.3 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.3 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.8 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.4 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.4 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.0 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.3 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.0 | 4.2 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.7 | GO:0009411 | response to UV(GO:0009411) |
0.0 | 0.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.0 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.0 | 0.0 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.0 | 1.4 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.0 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.0 | 0.0 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.0 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.0 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.0 | 0.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.0 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.0 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.1 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.1 | GO:0006497 | protein lipidation(GO:0006497) |
0.0 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.4 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.1 | GO:0070723 | response to cholesterol(GO:0070723) |
0.0 | 0.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 0.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.4 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.0 | 0.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 1.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.2 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.3 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.0 | 0.1 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.4 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.0 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.3 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.0 | 0.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.0 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.3 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.4 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
0.0 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.0 | 0.2 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.0 | 0.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.2 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.0 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.0 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.0 | 0.1 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.0 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.1 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.0 | 0.1 | GO:0034440 | lipid oxidation(GO:0034440) |
0.0 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 2.5 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.0 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.0 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.0 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0071827 | plasma lipoprotein particle organization(GO:0071827) |
0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.0 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.2 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.0 | 0.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.0 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.4 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.0 | 0.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.0 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.0 | 0.1 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.0 | 0.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 1.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0010841 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.0 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.0 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.0 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.0 | 0.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.0 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.0 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.0 | 0.2 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.0 | GO:0036503 | ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.0 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.0 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.0 | 0.2 | GO:1903050 | regulation of proteolysis involved in cellular protein catabolic process(GO:1903050) |
0.0 | 0.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.3 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.0 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.0 | 0.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.0 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.0 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.0 | 0.1 | GO:0034776 | response to histamine(GO:0034776) |
0.0 | 0.0 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.0 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.0 | GO:0072576 | liver morphogenesis(GO:0072576) |
0.0 | 0.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.0 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.5 | 4.4 | GO:0031523 | Myb complex(GO:0031523) |
1.4 | 4.3 | GO:0097443 | sorting endosome(GO:0097443) |
1.3 | 6.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.3 | 3.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.2 | 4.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.2 | 1.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.1 | 5.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.1 | 4.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.0 | 5.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.9 | 9.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.9 | 2.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.9 | 4.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 4.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.8 | 1.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.7 | 3.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.7 | 2.9 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.7 | 4.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 2.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.7 | 2.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.7 | 3.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 2.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.6 | 2.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.6 | 2.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.6 | 0.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 1.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 7.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.5 | 2.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 5.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 2.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 2.0 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 2.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 1.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.5 | 5.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.5 | 2.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 4.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.5 | 1.9 | GO:1990130 | Iml1 complex(GO:1990130) |
0.5 | 1.8 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.5 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.5 | 2.3 | GO:0005818 | aster(GO:0005818) |
0.5 | 2.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.4 | 1.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 3.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 6.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 6.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.4 | 6.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 4.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 1.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 2.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 1.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 4.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 3.0 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 1.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 1.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 1.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 4.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 5.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 1.4 | GO:0016234 | inclusion body(GO:0016234) |
0.3 | 0.3 | GO:1903349 | extrinsic component of omegasome membrane(GO:0097629) omegasome membrane(GO:1903349) |
0.3 | 1.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 2.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 1.7 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 0.7 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 1.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 1.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 4.8 | GO:0031430 | M band(GO:0031430) |
0.3 | 2.6 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 1.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 3.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 1.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.8 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 4.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 3.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 31.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.3 | 2.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 2.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 2.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 9.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 0.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.3 | 1.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 0.8 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 4.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 2.8 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 4.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 6.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 2.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 4.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 22.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 2.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 1.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 2.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 1.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 10.5 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 0.7 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 2.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 2.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 15.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 3.4 | GO:0043034 | costamere(GO:0043034) |
0.2 | 1.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 12.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 3.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 5.6 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 2.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 3.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 1.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 3.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 0.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 4.7 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 1.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 0.6 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.2 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.2 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 9.2 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 7.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 16.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 0.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 3.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 0.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 1.1 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.9 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 3.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 1.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 1.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 5.0 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.2 | 0.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 1.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 2.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.7 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 4.7 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 1.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 1.0 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 7.7 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.2 | 9.8 | GO:0030496 | midbody(GO:0030496) |
0.2 | 1.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.1 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 1.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 1.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.8 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.8 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 9.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 2.6 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.6 | GO:0031672 | A band(GO:0031672) |
0.1 | 4.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 5.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 12.3 | GO:0005903 | brush border(GO:0005903) |
0.1 | 1.0 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 2.7 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 5.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.9 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 1.5 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 1.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 4.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 1.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 1.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 8.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 7.6 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 1.0 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 3.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.1 | 1.0 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 2.4 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 12.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 4.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 7.2 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 6.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 1.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 2.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 3.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 1.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.4 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 10.2 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 2.9 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 16.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 3.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 2.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.2 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 1.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 4.4 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.1 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 2.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 1.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 5.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 7.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 4.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 2.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 4.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 2.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 3.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 14.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 1.1 | GO:0044452 | nucleolar part(GO:0044452) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 47.3 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 13.7 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.2 | GO:0032806 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 0.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 6.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 2.9 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 41.7 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 1.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 2.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 6.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 5.7 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.3 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.0 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 36.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 1.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 6.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 7.8 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 1.1 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 19.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 2.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.0 | 0.1 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.6 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.0 | 1.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 7.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.0 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.6 | 10.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.5 | 7.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
2.5 | 7.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.2 | 8.8 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
2.2 | 6.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.7 | 10.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.7 | 6.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.7 | 6.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.5 | 4.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.5 | 5.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.4 | 5.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.3 | 5.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.3 | 4.0 | GO:0019862 | IgA binding(GO:0019862) |
1.3 | 6.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.3 | 3.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.2 | 4.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.2 | 14.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.2 | 2.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.2 | 4.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.2 | 9.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
1.1 | 4.5 | GO:0015232 | heme transporter activity(GO:0015232) |
1.1 | 3.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.0 | 3.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.0 | 3.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.0 | 6.8 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.0 | 4.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.9 | 3.6 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 3.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.9 | 0.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.9 | 3.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.8 | 3.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.8 | 1.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.8 | 3.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.8 | 5.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.8 | 4.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.8 | 3.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 2.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.7 | 6.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.7 | 7.5 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.7 | 7.3 | GO:0019841 | retinol binding(GO:0019841) |
0.7 | 3.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.7 | 2.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.7 | 4.9 | GO:0005536 | glucose binding(GO:0005536) |
0.7 | 2.1 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.7 | 2.8 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.7 | 3.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 5.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.7 | 6.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.7 | 2.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 2.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.7 | 2.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.6 | 2.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.6 | 2.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 2.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.6 | 5.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.6 | 2.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.6 | 1.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 9.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.6 | 1.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 1.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.6 | 1.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.6 | 2.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 2.9 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.6 | 10.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.6 | 4.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 2.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 2.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 2.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 1.7 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.6 | 1.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 5.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.6 | 2.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.6 | 5.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 1.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.5 | 2.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 4.8 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.5 | 1.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.5 | 3.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 6.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.5 | 1.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 2.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 2.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.5 | 4.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 1.0 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.5 | 5.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 2.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 3.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 1.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 2.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 4.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 2.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.5 | 1.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.5 | 1.4 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.5 | 1.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 1.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 0.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.5 | 2.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 14.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.5 | 2.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 1.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 1.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.4 | 8.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.4 | 2.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.4 | 1.8 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 3.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.4 | 1.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.4 | 5.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.4 | 1.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 2.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.4 | 2.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 12.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 1.2 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 1.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.4 | 0.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 1.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 12.5 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 2.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 2.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 2.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 8.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 1.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 3.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 3.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 1.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 0.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 4.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 1.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 1.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 4.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.4 | 1.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 4.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 1.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 3.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 1.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 2.8 | GO:0031386 | protein tag(GO:0031386) |
0.4 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 1.4 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 1.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 14.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 2.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 1.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 3.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 7.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 5.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 4.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 5.7 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 1.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 1.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 1.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 1.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 2.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 0.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 1.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 2.9 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 1.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 1.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 3.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 4.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 0.9 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 1.6 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.3 | 0.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 0.9 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 1.2 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 0.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 2.4 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.3 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 1.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 3.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 8.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 8.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 1.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 2.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 0.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 3.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 1.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 4.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 2.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 0.8 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 3.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 2.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 3.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 0.8 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 0.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 1.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 4.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 1.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 1.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 0.8 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 1.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 2.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 0.5 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 1.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 0.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 1.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 0.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 3.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 4.2 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 2.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 1.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.7 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.2 | 2.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 2.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 2.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.5 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 1.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 1.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 2.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 1.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 1.1 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 7.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 2.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 1.3 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 4.2 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 3.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.2 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 2.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 2.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 1.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 5.7 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 5.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 5.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 11.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 2.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 2.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 0.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 3.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 1.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 4.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 0.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 3.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 1.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 30.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 0.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 4.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 1.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.4 | GO:0072542 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
0.2 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 2.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.2 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.2 | 1.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 1.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 1.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 4.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.6 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.2 | 2.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.2 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 1.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 3.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.9 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 5.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 2.6 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 1.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 1.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.3 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 1.7 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 1.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 10.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 5.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.5 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.5 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.2 | 0.8 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.2 | 0.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 6.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 1.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.8 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 2.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 3.0 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.2 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 3.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 1.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 1.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 3.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 2.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.8 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 1.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.6 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 2.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 3.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 1.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.1 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.1 | 1.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 2.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 1.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 3.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 5.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 1.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 2.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 5.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 5.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.6 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.6 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 1.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.0 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 3.1 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.4 | GO:0019117 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.8 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 1.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 2.3 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 1.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 2.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 1.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 1.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 7.4 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 2.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 2.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 2.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 1.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.4 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.3 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 2.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.2 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 3.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.5 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 1.3 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.4 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 6.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 7.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 1.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.0 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 1.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 4.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 2.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 11.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 3.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.8 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 1.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 3.4 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.2 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 1.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.1 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 1.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.7 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.1 | 0.8 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.4 | GO:0042299 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 32.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 2.7 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 4.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 1.1 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 4.0 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 1.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 1.2 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 3.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 1.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 1.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 1.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0051379 | epinephrine binding(GO:0051379) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.4 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0008409 | 5'-3' exoribonuclease activity(GO:0004534) 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 0.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 1.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.0 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 2.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.9 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 1.8 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.1 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.0 | 0.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 1.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.8 | 20.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.7 | 15.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.5 | 3.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 13.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 5.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 17.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 0.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 8.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 4.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 4.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 12.6 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 5.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 9.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 11.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 1.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 6.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 5.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 5.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 2.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 2.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 14.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 7.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 4.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 11.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 3.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 3.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 2.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 7.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 4.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 1.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 1.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 1.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 2.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 1.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 0.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 3.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 5.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 8.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 3.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 3.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 6.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 4.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 3.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 6.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 2.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 1.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 3.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 1.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 3.8 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 0.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 1.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 9.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 3.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 7.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 2.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 4.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 4.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 2.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 2.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.2 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 6.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 14.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.0 | 10.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 6.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.9 | 7.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 19.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.8 | 12.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.7 | 7.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 18.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.6 | 14.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 3.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.6 | 0.6 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.6 | 6.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 14.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 3.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 4.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.5 | 6.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 10.9 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.5 | 5.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.4 | 3.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 15.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 9.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 5.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 4.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 11.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 3.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 2.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 7.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 2.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 3.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 4.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.3 | 5.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 4.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 3.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 1.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.3 | 5.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 2.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 0.6 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.3 | 4.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.3 | 2.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 5.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 1.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 3.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 1.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 10.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 1.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 6.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 2.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 1.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 3.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 1.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 3.6 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.3 | 4.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 2.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 7.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 4.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 2.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 15.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 2.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 1.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 3.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 2.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 16.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 1.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 3.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 6.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 2.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 2.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 3.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 1.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 4.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 0.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 0.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 7.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 10.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 0.9 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.2 | 14.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 7.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 4.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 16.0 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.2 | 1.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 1.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 2.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 1.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 1.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 3.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 18.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 2.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 3.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 4.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 2.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 13.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.2 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 1.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 3.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 3.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 3.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.2 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.1 | 1.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.7 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 2.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.3 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.1 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 3.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 2.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.2 | REACTOME SIGNALING BY GPCR | Genes involved in Signaling by GPCR |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.4 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.3 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.1 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |